Hospital clinicians' responsiveness to assay cost feedback: A prospective blinded controlled intervention study

JAMA Internal Medicine

Volumn 173, Issue 17, 2013, Pages 1654-1655

  Fogarty, Andrew W ^a   Sturrock, Nigel ^b   Premji, Karim ^c   Prinsloo, Peter ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BLOOD CELL COUNT; CLINICAL PRACTICE; HEALTH CARE COST; HOSPITAL COST; HUMAN; PRIORITY JOURNAL;

C-REACTIVE PROTEIN; COSTS AND COST ANALYSIS; FEE-FOR-SERVICE PLANS; GREAT BRITAIN; HOSPITAL COSTS; HOSPITALISTS; HUMANS; INTERVENTION STUDIES; PROSPECTIVE STUDIES;

EID: 84884679862     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.8211     Document Type: Article

References (5)

1. Organisation for Economic Co-operation and Development (OECD). Health at a Glance 2011: OECD Indicators. Paris, France: OECD Publishing; 2011. doi:10.1787/health-glance-2011-en. Accessed September 26, 2012.
2. Martini M, Garrett N, Lindquist T, Isham GJ. The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by major practice category. Health Research Educational Trust. 2007;42:201-218. (Pubitemid 46145533)
3. The NHS Confederation. Variation in Healthcare: Does it Matter and Can Anything Be Done? London, England: NHS Confederation; 2004.
4. Sood R, Sood A, Ghosh AK. Non-evidence-based variables affecting physicians' test-ordering tendencies: a systematic review. Neth J Med. 2007;65(5):167-177. (Pubitemid 47161618)
5. Rao GG, Crook M, Tillyer ML. Pathology tests: is the time for demand management ripe at last? J Clin Pathol. 2003;56(4):243-248. (Pubitemid 36459791)